VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

ClearPoint Neuro, Inc. (CLPT) Total Return Calculator with Dividends Reinvested

ClearPoint Neuro, Inc.

Popular:

The total return for ClearPoint Neuro, Inc. (CLPT) stock is -12.11% over the past 12 months. So far it's down 16.75% this year. The 5-year total return is -38.33%, meaning $10,000 invested in CLPT stock 5 years ago would be worth $6,167 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in CLPT 1 year ago, it would be worth $8,196 today — you'd have lost $1,804.

With Dividends Reinvested$8,196-18.04%

Price Only (No DRIP)$8,196-18.04%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in CLPT

1Y$8,789-$1,211 (-12.1%)-12.1% CAGR

3Y$12,167+$2,167 (+21.7%)6.8% CAGR

5Y$6,167-$3,833 (-38.3%)-9.2% CAGR

10Y$7,487-$2,513 (-25.1%)-2.9% CAGR

15Y$3,893-$6,107 (-61.1%)-6.1% CAGR

20Y$3,893-$6,107 (-61.1%)-4.6% CAGR

30Y$3,893-$6,107 (-61.1%)-3.1% CAGR

ClearPoint Neuro, Inc. did not pay dividends during this period. Total return = price return.

Loading CLPT total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-16.75%	—	-16.75%	—	$8,325
1Y	-12.11%	-12.11%	-12.11%	—	$8,789
3Y	+21.67%	6.76%	+21.67%	—	$12,167
5Y	-38.33%	-9.22%	-38.33%	—	$6,167
10Y	-25.13%	-2.85%	-25.13%	—	$7,487
15Y	-61.07%	-6.10%	-61.07%	—	$3,893
20Y	-61.07%	-4.61%	-61.07%	—	$3,893
30Y	-61.07%	-3.10%	-61.07%	—	$3,893

Risk & Highlights

Best Year+224.29%2020

Worst Year-76.39%2016

Max Drawdown-70.74%2025-10-08 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-10.41%	-10.41%	—	+0.41%	-10.8pp
2025	-11.97%	-11.97%	—	+16.64%	-28.6pp
2024	+127.51%	+127.51%	—	+24.00%	+103.5pp
2023	-18.39%	-18.39%	—	+24.81%	-43.2pp
2022	-26.98%	-26.98%	—	-19.95%	-7.0pp

CLPT underperformed the S&P 500 by 42.49pp over the past year (-12.11% vs +30.37%).

Loading summary...

CLPT Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
CLPTClearPoint Neuro, Inc.	$343M	+28.8%	-16.7%	-12.1%	—	+21.7%	-38.3%	-25.1%
NVCRNovoCure Limited	$1.9B	+62.6%	+28.3%	+1.1%	—	-75.7%	-91.3%	+30.3%
INVAInnoviva, Inc.	$1.9B	-2.1%	+14.7%	+21.7%	—	+95.2%	+94.4%	+94.9%
ABTAbbott Laboratories	$151.3B	-14.5%	-28.9%	-33.2%	+1.8pp	-15.4%	-17.9%	+173.7%
MDTMedtronic plc	$99.9B	-9.8%	-18.1%	-2.8%	+3.4pp	-4.2%	-27.7%	+26.5%
ANGOAngioDynamics, Inc.	$469M	+16.2%	-11.1%	+28.5%	—	+25.8%	-53.3%	-9.2%
ATECAlphatec Holdings, Inc.	$1.2B	-29.7%	-62.7%	-37.8%	—	-47.8%	-48.7%	+225.4%
GEGE Aerospace	$316.2B	+4.9%	-5.5%	+44.9%	+0.7pp	+280.0%	+362.5%	+121.0%
GEHCGE HealthCare Technologies Inc.	$27.9B	-12.0%	-25.9%	-10.7%	+0.2pp	-22.2%	+2.9%	+2.9%
SYKStryker Corporation	$112.7B	-11.4%	-15.2%	-22.5%	+0.9pp	+5.5%	+21.5%	+187.1%
ISRGIntuitive Surgical, Inc.	$161.1B	+0.1%	-19.3%	-15.4%	—	+49.6%	+58.7%	+554.2%

Compare:CLPT vs NVCR CLPT vs INVA CLPT vs ABT CLPT vs NVCR vs INVA

About CLPT Dividend Returns

ClearPoint Neuro, Inc. (CLPT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CLPT over the past year?

ClearPoint Neuro, Inc. (CLPT) delivered a return of -12.11% over the past year. Since CLPT does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in CLPT be worth today?

A $10,000 investment in ClearPoint Neuro, Inc. one year ago would be worth $8,789 today, representing a loss of $1,211.

Q3Does CLPT pay dividends?

ClearPoint Neuro, Inc. (CLPT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CLPT, the total return equals the price-only return.

Q4Did CLPT beat the S&P 500?

No, ClearPoint Neuro, Inc. (CLPT) underperformed the S&P 500 by 42.49 percentage points over the past year. CLPT delivered a total return of -12.11%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed CLPT by 42.49pp during this period.

Q5What is CLPT's worst drawdown?

ClearPoint Neuro, Inc. (CLPT) experienced a maximum drawdown of -70.74% over the past year, declining from its peak on 2025-10-08 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CLPT's long-term total return over 10, 20, or 30 years?

Here are ClearPoint Neuro, Inc. (CLPT)'s long-term returns with dividends reinvested. Over 10 years, the total return is -25.1% (-2.9% CAGR) — $10,000 would have grown to $7,487. Over 20 years: -61.1% total return (-4.6% CAGR) — $10,000 → $3,893. Over 30 years: -61.1% total return (-3.1% CAGR) — $10,000 → $3,893. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CLPT's best and worst year?

ClearPoint Neuro, Inc.'s best calendar year was 2020 with a total return of 224.3%. Its worst year was 2016 with a total return of -76.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 300.7 percentage points.